Is there a neuroendocrinological rationale for testosterone as a therapeutic option in depression?

Journal of Psychopharmacology

Volumn 23, Issue 7, 2009, Pages 841-853

  Ebinger, M ^a,c   Sievers, C ^a,c   Ivan, D ^a,b   Schneider, H J ^a   Stalla, G K ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

^c c/o Dr Med Caroline Sievers ^*  (Germany)

Author keywords

Depression; Neuroendocrinology; Testosterone

Indexed keywords

ALPHA DIHYDROTESTOSTERONE; ANDROGEN RECEPTOR; ANDROSTANOLONE; AROMATASE; DOPAMINE; ESTRADIOL; HYDROCORTISONE; METHYLTESTOSTERONE; NEUROSTEROID; NORADRENALIN; OXYTOCIN; PRASTERONE; SEROTONIN; STEROID 5ALPHA REDUCTASE; STEROID 5BETA REDUCTASE; TESTOSTERONE; TESTOSTERONE ENANTATE; TESTOSTERONE UNDECANOATE; UNCLASSIFIED DRUG; VASOPRESSIN; VENLAFAXINE;

AMYGDALOID NUCLEUS; ANDROGEN BLOOD LEVEL; ANDROGEN DEFICIENCY; ANDROGEN THERAPY; BECK DEPRESSION INVENTORY; BRAIN PERFUSION; CLINICAL GLOBAL IMPRESSION SCALE; DEPRESSION; DOPAMINERGIC SYSTEM; DYSTHYMIA; FORCED SWIMMING TEST; GEL; HAMILTON SCALE; HIPPOCAMPUS; HUMAN; HYPOGONADISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INVOLUTIONAL DEPRESSION; LIBIDO; MENTAL DISEASE; MOOD; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROENDOCRINE SYSTEM; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC SYSTEM; SEX DIFFERENCE; TESTOSTERONE BLOOD LEVEL;

ANIMALS; BRAIN; CLINICAL TRIALS AS TOPIC; DEPRESSION; DOPAMINE; HUMANS; NEUROSECRETORY SYSTEMS; NEUROTRANSMITTER AGENTS; NOREPINEPHRINE; RECEPTORS, ANDROGEN; SEROTONIN; SEX CHARACTERISTICS; TESTOSTERONE;

EID: 69049090062     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108092337     Document Type: Review

References (179)

1. Aikey JL. Nyby JG. Anmuth DM. James PJ. (2002) Testosterone rapidly reduces anxiety in male house mice (Mus musculus). Horm Behav 42: 448-460.
2. Alexander GM. Swerdloff RS. Wang C. Davidson T. McDonald V. Steiner B. (1998) Androgen-behavior correlations in hypogonadal men and eugonadal men. II. Cognitive abilities. Horm Behav 33: 85-94.
3. Almeida OP. Waterreus A. Spry N. Flicker L. Martins RN. (2004) One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men. Psychoneuroendocrinology 29: 1071-1081.
4. Altman J. Das GD. (1965) Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol 124: 319-335.
5. Amsterdam JD. Winokur A. Caroff S. Snyder P. (1981) Gonadotropin release after administration of GnRH in depressed patients and healthy volunteers. J Affect Disord 3: 367-380.
6. Angst J. Gamma A. Gastpar M. Lepine JP. Mendlewicz J. Tylee A. (2002) Gender differences in depression. Epidemiological findings from the European DEPRES I and II studies. Eur Arch Psychiatry Clin Neurosci 252: 201-209.
7. Archer J. (1991) The influence of testosterone on human aggression. Br J Psychol 82: 1-28.
8. Arlt W. (2006) Androgen therapy in women. Eur J Endocrinol 154: 1-11.
9. Azad N. Pitale S. Barnes WE. Friedman N. (2003) Testosterone treatment enhances regional brain perfusion in hypogonadal men. J Clin Endocrinol Metab 88: 3064-3068.
10. Bachmann G. Bancroft J. Braunstein G. Burger H. Davis S. Dennerstein L. (2002) Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil Steril 77: 660-665.
11. Baischer W. Koinig G. Hartmann B. Huber J. Langer G. (1995) Hypothalamic-pituitary-gonadal axis in depressed premenopausal women: elevated blood testosterone concentrations compared to normal controls. Psychoneuroendocrinology 20: 553-559.
12. Bakhshi V. Elliott M. Gentili A. Godschalk M. Mulligan T. (2000) Testosterone improves rehabilitation outcomes in ill older men. J Am Geriatr Soc 48: 550-553.
13. Balthazart J. Ball GF. (2006) Is brain estradiol a hormone or a neurotransmitter. Trends Neurosci 29: 241-249.
14. Barnhart KT. Freeman E. Grisso JA. Rader DJ. Sammel M. Kapoor S. (1999) The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. J Clin Endocrinol Metab 84: 3896-3902.
15. Barrett-Connor E. Goodman-Gruen D. Patay B. (1999a) Endogenous sex hormones and cognitive function in older men. J Clin Endocrinol Metab 84: 3681-3685.
16. Barrett-Connor E. von Muhlen DG. Kritz-Silverstein D. (1999b) Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo Study. J Clin Endocrinol Metab 84: 573-577.
17. Bebbington P. Dunn G. Jenkins R. Lewis G. Brugha T. Farrell M. (2003) The influence of age and sex on the prevalence of depressive conditions: report from the National Survey of Psychiatric Morbidity. Int Rev Psychiatry 15: 74-83.
18. Bell S. Shipman M. Bystritsky A. Haifley T. (2006) Fluoxetine treatment and testosterone levels. Ann Clin Psychiatry 18: 19-22.
19. Bhasin S. Storer TW. Asbel-Sethi N. Kilbourne A. Hays R. Sinha-Hikim I. (1998) Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels. J Clin Endocrinol Metab 83: 3155-3162.
20. Bhasin S. Storer TW. Javanbakht M. Berman N. Yarasheski KE. Phillips J. (2000) Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels. JAMA 283: 763-770.
21. Booth A. Johnson DR. Granger DA. (1999) Testosterone and men's depression: the role of social behavior. J Health Soc Behav 40: 130-140.
22. Breedlove SM. Arnold AP. (1983) Hormonal control of a developing neuromuscular system. II. Sensitive periods for the androgen-induced masculinization of the rat spinal nucleus of the bulbocavernosus. J Neurosci 3: 424-432.
23. Broadbear JH. Pierce BN. Clarke IJ. Canny BJ. (2005) Role of sex and sex steroids in mediating pituitary-adrenal responses to acute buspirone treatment in sheep. J Neuroendocrinol 17: 804-810.
24. Brower KJ. Blow FC. Young JP. Hill EM. (1991) Symptoms and correlates of anabolic-androgenic steroid dependence. Br J Addict 86: 759-768.
25. Brugue E. Vieta E. (2007) Atypical antipsychotics in bipolar depression: neurobiological basis and clinical implications. Prog Neuropsychopharmacol Biol Psychiatry 31: 275-282.
26. Bschor T. Lewitzka U. Sasse J. Adli M. Koberle U. Bauer M. (2003) Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms. Pharmacopsychiatry 36 (Suppl. 3). S230-S234.
27. Burris AS. Banks SM. Carter CS. Davidson JM. Sherins RJ. (1992) A long-term, prospective study of the physiologic and behavioral effects of hormone replacement in untreated hypogonadal men. J Androl 13: 297-304.
28. Canoine V. Fusani L. Schlinger B. Hau M. (2007) Low sex steroids, high steroid receptors: Increasing the sensitivity of the nonreproductive brain. Dev Neurobiol 67: 57-67.
29. Carpenter LL. Friehs GM. Tyrka AR. Rasmussen S. Price LH. Greenberg BD. (2006) Vagus nerve stimulation and deep brain stimulation for treatment resistant depression. Med Health R I 89: 140-141.
30. Caspi A. Sugden K. Moffitt TE. Taylor A. Craig IW. Harrington H. (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301: 386-389.
31. Cavallini G. Caracciolo S. Vitali G. Modenini F. Biagiotti G. (2004) Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging. Urology 63: 641-646.
32. Charlier TD. Ball GF. Balthazart J. (2006) Plasticity in the expression of the steroid receptor coactivator 1 in the Japanese quail brain: effect of sex, testosterone, stress and time of the day. Neuroscience 140: 1381-1394.
33. Chisu V. Manca P. Lepore G. Gadau S. Zedda M. Farina V. (2006) Testosterone induces neuroprotection from oxidative stress. Effects on catalase activity and 3-nitro-L-tyrosine incorporation into alpha-tubulin in a mouse neuroblastoma cell line. Arch Ital Biol 144: 63-73.
34. Christiansen K. (2001) Behavioural effects of androgen in men and women. J Endocrinol 170: 39-48.
35. Colangelo LA. Sharp L. Kopp P. Scholtens D. Chiu BC. Liu K. Gapstur SM. (2007) Total testosterone, androgen receptor polymorphism, and depressive symptoms in young black and white men: The CARDIA Male Hormone Study. Psychoneuroendocrinology 32: 951-958.
36. Commins D. Yahr P. (1984) Adult testosterone levels influence the morphology of a sexually dimorphic area in the Mongolian gerbil brain. J Comp Neurol 224: 132-140.
37. Coppen A. Wood K. (1982) 5-Hydroxytryptamine in the pathogenesis of affective disorders. Adv Biochem Psychopharmacol 34: 249-258.
38. Daniell HW. Lentz R. Mazer NA. (2006) Open-label pilot study of testosterone patch therapy in men with opioid-induced androgen deficiency. J Pain 7: 200-210.
39. Davies RH. Harris B. Thomas DR. Cook N. Read G. Riad-Fahmy D. (1992) Salivary testosterone levels and major depressive illness in men. Br J Psychiatry 161: 629-632.
40. Davis SR. Goldstat R. Papalia MA. Shah S. Kulkarni J. Donath S. (2006) Effects of aromatase inhibition on sexual function and well-being in postmenopausal women treated with testosterone: a randomized, placebo-controlled trial. Menopause 13: 37-45.
41. Dawood T. Williams MR. Fullerton MJ. Myles K. Schuijers J. Funder JW. (2005) Glucocorticoid responses to stress in castrate and testosterone-replaced rams. Regul Pept 125: 47-53.
42. Delhez M. Hansenne M. Legros JJ. (2003) Andropause and psychopathology: minor symptoms rather than pathological ones. Psychoneuroendocrinology 28: 863-874.
43. Dias BG. Crews D. (2006) Serotonergic modulation of male-like pseudocopulatory behavior in the parthenogenetic whiptail lizard, Cnemidophorus uniparens. Horm Behav 50: 401-409.
44. Dias RS. Kerr-Correa F. Moreno RA. Trinca LA. Pontes A. Halbe HW. (2006) Efficacy of hormone therapy with and without methyltestosterone augmentation of venlafaxine in the treatment of postmenopausal depression: a double-blind controlled pilot study. Menopause 13: 202-211.
45. Dickerman RD. McConathy WJ. (1997) Testosterone, vasopressin and depression. Prog Neuropsychopharmacol Biol Psychiatry 21: 247-248.
46. Doering CH. Brodie HK. Kraemer HC. Moos RH. Becker HB. Hamburg DA. (1975) Negative affect and plasma testosterone: a longitudinal human study. Psychosom Med 37: 484-491.
47. Dubois-Dauphin M. Barberis C. de Bilbao F. (1996) Vasopressin receptors in the mouse (Mus musculus) brain: sex-related expression in the medial preoptic area and hypothalamus. Brain Res 743: 32-39.
48. Ebinger M. Behl C. Rosenhagen M. Uhr M. (2007) P-glycoprotein has negligible effects on estradiol and testosterone in mice. Neurosci Lett 427: 6-9.
49. Edinger KL. Frye CA. (2005) Testosterone's anti-anxiety and analgesic effects may be due in part to actions of its 5alpha-reduced metabolites in the hippocampus. Psychoneuroendocrinology 30: 418-430.
50. Edinger KL. Frye CA. (2006) Intrahippocampal administration of an androgen receptor antagonist, flutamide, can increase anxiety-like behavior in intact and DHT-replaced male rats. Horm Behav 50: 216-222.
51. Engesser-Cesar C. Anderson AJ. Cotman CW. (2007) Wheel running and fluoxetine antidepressant treatment have differential effects in the hippocampus and the spinal cord. Neuroscience 144: 1033-1044.
52. Estrada M. Varshney A. Ehrlich BE. (2006) Elevated testosterone induces apoptosis in neuronal cells. J Biol Chem 281: 25492-25501.
53. Fink G. Sumner B. Rosie R. Wilson H. McQueen J. (1999) Androgen actions on central serotonin neurotransmission: relevance for mood, mental state and memory. Behav Brain Res 105: 53-68.
54. Fink G. Sumner BE. Mcqueen JK. Wilson H. Rosie R. (1998) Sex steroid control of mood, mental state and memory. Clin Exp Pharmacol Physiol 25: 764-775.
55. Floter A. Nathorst-Boos J. Carlstrom K. von Schoultz B. (2002) Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being. Climacteric 5: 357-365.
56. Forlano PM. Schlinger BA. Bass AH. (2006) Brain aromatase: new lessons from non-mammalian model systems. Front Neuroendocrinol 27: 247-274.
57. Galea LA. Spritzer MD. Barker JM. Pawluski JL. (2006) Gonadal hormone modulation of hippocampal neurogenesis in the adult. Hippocampus 16: 225-232.
58. Gershenfeld HK. Philibert RA. Boehm GW. (2005) Looking forward in geriatric anxiety and depression: implications of basic science for the future. Am J Geriatr Psychiatry 13: 1027-1040.
59. Goldstat R. Briganti E. Tran J. Wolfe R. Davis SR. (2003) Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women. Menopause 10: 390-398.
60. Graham CA. Bancroft J. Doll HA. Greco T. Tanner A. (2007) Does oral contraceptive-induced reduction in free testosterone adversely affect the sexuality or mood of women. Psychoneuroendocrinology 32: 246-255.
61. Gray PB. Singh AB. Woodhouse LJ. Storer TW. Casaburi R. Dzekov J. (2005) Dose-dependent effects of testosterone on sexual function, mood, and visuospatial cognition in older men. J Clin Endocrinol Metab 90: 3838-3846.
62. Greenberg RM. Kellner CH. (2005) Electroconvulsive therapy: a selected review. Am J Geriatr Psychiatry 13: 268-281.
63. Grimes JM. Ricci LA. Melloni RH. (2006) Plasticity in anterior hypothalamic vasopressin correlates with aggression during anabolic-androgenic steroid withdrawal in hamsters. Behav Neurosci 120: 115-124.
64. Grinspoon S. Corcoran C. Stanley T. Baaj A. Basgoz N. Klibanski A. (2000) Effects of hypogonadism and testosterone administration on depression indices in HIV-infected men. J Clin Endocrinol Metab 85: 60-65.
65. Haren MT. Malmstrom TK. Banks WA. Patrick P. Miller DK. Morley JE. (2007) Lower serum DHEAS levels are associated with a higher degree of physical disability and depressive symptoms in middle-aged to older African American women. Maturitas 57: 347-360.
66. Haren MT. Wittert GA. Chapman IM. Coates P. Morley JE. (2005) Effect of oral testosterone undecanoate on visuospatial cognition, mood and quality of life in elderly men with low-normal gonadal status. Maturitas 50: 124-133.
67. Hernandez-Rauda R. Aldegunde M. (2002) Effects of acute 17alpha-methyltestosterone, acute 17beta-estradiol, and chronic 17alpha-methyltestosterone on dopamine, norepinephrine and serotonin levels in the pituitary, hypothalamus and telencephalon of rainbow trout (Oncorhynchus mykiss). J Comp Physiol [B] 172: 659-667.
68. Heuett WJ. Qian H. (2006) A stochastic model of oscillatory blood testosterone levels. Bull Math Biol 68: 1383-1399.
69. Heuser I. (2002) Depression, endocrinologically a syndrome of premature aging. Maturitas 41 (Suppl. 1). S19-S23.
70. Holsboer F. (2003) High-quality antidepressant discovery by understanding stress hormone physiology. Ann N Y Acad Sci 1007: 394-404.
71. Houser BB. (1979) An investigation of the correlation between hormonal levels in males and mood, behavior and physical discomfort. Horm Behav 12: 185-197.
72. Iosifescu DV. Nierenberg AA. Mischoulon D. Perlis RH. Papakostas GI. Ryan JL. (2005) An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder. J Clin Psychiatry 66: 1038-1042.
73. Jacobs C. Van Den Broeck W. Simoens P. (2006) Increased number of neurons expressing androgen receptor in the basolateral amygdala of pathologically aggressive dogs. J Vet Med A Physiol Pathol Clin Med 53: 334-339.
74. Janowsky JS. Chavez B. Orwoll E. (2000) Sex steroids modify working memory. J Cogn Neurosci 12: 407-414.
75. Janowsky JS. Oviatt SK. Orwoll ES. (1994) Testosterone influences spatial cognition in older men. Behav Neurosci 108: 325-332.
76. Kaufman JM. Vermeulen A. (2005) The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 26: 833-876.
77. Keck ME. (2006) Corticotropin-releasing factor, vasopressin and receptor systems in depression and anxiety. Amino Acids 31: 241-250.
78. Keck ME. Wigger A. Welt T. Muller MB. Gesing A. Reul JM. (2002) Vasopressin mediates the response of the combined dexamethasone/CRH test in hyper-anxious rats: implications for pathogenesis of affective disorders. Neuropsychopharmacology 26: 94-105.
79. Kenny AM. Fabregas G. Song C. Biskup B. Bellantonio S. (2004) Effects of testosterone on behavior, depression, and cognitive function in older men with mild cognitive loss. J Gerontol A Biol Sci Med Sci 59: 75-78.
80. Kessler RC. (2003) Epidemiology of women and depression. J Affect Disord 74: 5-13.
81. Kessler RC. McGonagle KA. Zhao S. Nelson CB. Hughes M. Eshleman S. (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51: 8-19.
82. Kornstein SG. Schatzberg AF. Thase ME. Yonkers KA. McCullough JP. Keitner GI. (2000) Gender differences in chronic major and double depression. J Affect Disord 60: 1-11.
83. Kunelius P. Lukkarinen O. Hannuksela ML. Itkonen O. Tapanainen JS. (2002) The effects of transdermal dihydrotestosterone in the aging male: a prospective, randomized, double blind study. J Clin Endocrinol Metab 87: 1467-1472.
84. Kurz EM. Sengelaub DR. Arnold AP. (1986) Androgens regulate the dendritic length of mammalian motoneurons in adulthood. Science 232: 395-398.
85. Levitt AJ. Joffe RT. (1988) Total and free testosterone in depressed men. Acta Psychiatr Scand 77: 346-348.
86. Liu PY. Yee B. Wishart SM. Jimenez M. Jung DG. Grunstein RR. (2003) The short-term effects of high-dose testosterone on sleep, breathing, and function in older men. J Clin Endocrinol Metab 88: 3605-3613.
87. Lucassen PJ. Heine VM. Muller MB. van der Beek EM. Wiegant VM. De Kloet ER. (2006) Stress, depression and hippocampal apoptosis. CNS Neurol Disord Drug Targets 5: 531-546.
88. Luisi M. Franchi F. (1980) Double-blind group comparative study of testosterone undecanoate and mesterolone in hypogonadal male patients. J Endocrinol Invest 3: 305-308.
89. LY L. P., Jimenez, M, Zhuang, TN, Celermajer, DS, Conway, AJ, Handelsman, DJ (2001) A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency. J Clin Endocrinol Metab 86: 4078-4088.
90. MacLusky NJ. Hajszan T. Prange-Kiel J. Leranth C. (2006) Androgen modulation of hippocampal synaptic plasticity. Neuroscience 138: 957-965.
91. Maggi A. Perez J. (1985) Role of female gonadal hormones in the CNS: clinical and experimental aspects. Life Sci 37: 893-906.
92. Makhlouf, AA, Mohamed, MA, Seftel, AD, Neiderberger, C (2008) Hypogonadism is associated with overt depression symptoms in men with erectile dysfunction. Int J Impot Res 20: 157-161.
93. Martinez-Mota L. Fernandez-Guasti A. (2004) Testosterone-dependent antidepressant-like effect of noradrenergic but not of serotonergic drugs. Pharmacol Biochem Behav 78: 711-718.
94. Matsumoto AM. (1990) Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production. J Clin Endocrinol Metab 70: 282-287.
95. Mazur A. (1995) Biosocial models of deviant behavior among male army veterans. Biol Psychol 41: 271-293.
96. McEwen BS. Alves SE. (1999) Estrogen actions in the central nervous system. Endocr Rev 20: 279-307.
97. McMahon FJ. Buervenich S. Charney D. Lipsky R. Rush AJ. Wilson AF. (2006) Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am J Hum Genet 78: 804-814.
98. McNicholas TA. Dean JD. Mulder H. Carnegie C. Jones NA. (2003) A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function. BJU Int 91: 69-74.
99. Miller KK. Wexler TL. Zha AM. Lawson EA. Meenaghan EM. Misra M. (2007) Androgen deficiency: association with increased anxiety and depression symptom severity in anorexia nervosa. J Clin Psychiatry 68: 959-965.
100. Morley JE. (2003) Testosterone and behavior. Clin Geriatr Med 19: 605-616.
101. Morsink LF. Vogelzangs N. Nicklas BJ. Beekman AT. Satterfield S. Rubin SM. (2007) Associations between sex steroid hormone levels and depressive symptoms in elderly men and women: Results from the Health ABC study. Psychoneuroendocrinology.
102. Muller M. Grobbee DE. Thijssen JH. Van Den Beld AW. Van Der Schouw YT. (2003) Sex hormones and male health: effects on components of the frailty syndrome. Trends Endocrinol Metab 14: 289-296.
103. Muller MB. Holsboer F. (2006) Mice with mutations in the HPA-system as models for symptoms of depression. Biol Psychiatry 59: 1104-1115.
104. Myers LS. Dixen J. Morrissette D. Carmichael M. Davidson JM. (1990) Effects of estrogen, androgen, and progestin on sexual psychophysiology and behavior in postmenopausal women. J Clin Endocrinol Metab 70: 1124-1131.
105. Nemeroff CB. (2005) Use of atypical antipsychotics in refractory depression and anxiety. J Clin Psychiatry 66 (Suppl. 8). 13-21.
106. Newberg A. Amsterdam J. Shults J. (2007) Dopamine transporter density may be associated with the depressed affect in healthy subjects. Nucl Med Commun 28: 3-6.
107. O'Connor DB, Archer, J, Wu, FC (2004) Effects of testosterone on mood, aggression, and sexual behavior in young men: a double-blind, placebo-controlled, cross-over study. J Clin Endocrinol Metab 89: 2837-2845.
108. Orengo CA. Fullerton G. Tan R. (2004) Male depression: a review of gender concerns and testosterone therapy. Geriatrics 59: 24-30.
109. Orengo CA. Fullerton L. Kunik ME. (2005) Safety and efficacy of testosterone gel 1% augmentation in depressed men with partial response to antidepressant therapy. J Geriatr Psychiatry Neurol 18: 20-24.
110. Ozcan ME. Banoglu R. (2003) Gonadal hormones in schizophrenia and mood disorders. Eur Arch Psychiatry Clin Neurosci 253: 193-196.
111. Parducz A. Hajszan T. Maclusky NJ. Hoyk Z. Csakvari E. Kurunczi A. (2006) Synaptic remodeling induced by gonadal hormones: neuronal plasticity as a mediator of neuroendocrine and behavioral responses to steroids. Neuroscience 138: 977-985.
112. Park SK. Strouse DA. Selmanoff M. (1996) Prolactin- and testosterone-induced inhibition of LH secretion after orchidectomy: role of catecholaminergic neurones terminating in the diagonal band of Broca, medial preoptic nucleus and median eminence. J Endocrinol 148: 291-301.
113. Perry PJ. Yates WR. Williams RD. Andersen AE. MacIndoe JH. Lund BC. (2002) Testosterone therapy in late-life major depression in males. J Clin Psychiatry 63: 1096-1101.
114. Piccinelli M. Wilkinson G. (2000) Gender differences in depression. Critical review. Br J Psychiatry 177: 486-492.
115. Pope HG. Cohane GH. Kanayama G. Siegel AJ. Hudson JI. (2003) Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial. Am J Psychiatry 160: 105-111.
116. Pope HG. Katz DL. (1988) Affective and psychotic symptoms associated with anabolic steroid use. Am J Psychiatry 145: 487-490.
117. Pope HG. Katz DL. (1990) Homicide and near-homicide by anabolic steroid users. J Clin Psychiatry 51: 28-31.
118. Pope HG. Kouri EM. Hudson JI. (2000) Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial. Arch Gen Psychiatry 57: 133-140 discussion 155-156.
119. Poretsky L. Brillon DJ. Ferrando S. Chiu J. McElhiney M. Ferenczi A. (2006) Endocrine effects of oral dehydroepiandrosterone in men with HIV infection: a prospective, randomized, double-blind, placebo-controlled trial. Metabolism 55: 858-870.
120. Pozzo Miller LD. Aoki A. (1991) Stereological analysis of the hypothalamic ventromedial nucleus. II. Hormone-induced changes in the synaptogenic pattern. Brain Res Dev Brain Res 61: 189-196.
121. Putnam SK. Sato S. Riolo JV. Hull EM. (2005) Effects of testosterone metabolites on copulation, medial preoptic dopamine, and NOS-immunoreactivity in castrated male rats. Horm Behav 47: 513-522.
122. Rabkin JG. McElhiney MC. Rabkin R. McGrath PJ. Ferrando SJ. (2006) Placebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV/AIDS. Am J Psychiatry 163: 59-66.
123. Rabkin JG. Wagner GJ. McElhiney MC. Rabkin R. Lin SH. (2004) Testosterone versus fluoxetine for depression and fatigue in HIV/AIDS: a placebo-controlled trial. J Clin Psychopharmacol 24: 379-385.
124. Rabkin JG. Wagner GJ. Rabkin R. (2000) A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms. Arch Gen Psychiatry 57: 141-147 discussion 155-156.
125. Roselli CE. Resko JA. (2001) Cytochrome P450 aromatase (CYP19) in the non-human primate brain: distribution, regulation, and functional significance. J Steroid Biochem Mol Biol 79: 247-253.
126. Rubin RT. Poland RE. Lesser IM. (1989) Neuroendocrine aspects of primary endogenous depression VIII. Pituitary-gonadal axis activity in male patients and matched control subjects. Psychoneuroendocrinology 14: 217-229.
127. Rubinow DR. Schmidt PJ. (1996) Androgens, brain, and behavior. Am J Psychiatry 153: 974-984.
128. Rupprecht R. (2003) Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties. Psychoneuroendocrinology 28: 139-168.
129. Rupprecht R. Holsboer F. (1999) Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci 22: 410-416.
130. Rupprecht R. Rupprecht C. Rupprecht M. Noder M. Schwarz W. (1988) Different reactivity of the hypothalamo-pituitary-gonadal-axis in depression and normal controls. Pharmacopsychiatry 21: 438-439.
131. Sato T. Matsumoto T. Kawano H. Watanabe T. Uematsu Y. Sekine K. (2004) Brain masculinization requires androgen receptor function. Proc Natl Acad Sci U S A 101: 1673-1678.
132. Schlinger BA. (1997) The activity and expression of aromatase in songbirds. Brain Res Bull 44: 359-364.
133. Schmidt PJ. Berlin KL. Danaceau MA. Neeren A. Haq NA. Roca CA. (2004) The effects of pharmacologically induced hypogonadism on mood in healthy men. Arch Gen Psychiatry 61: 997-1004.
134. Schmidt PJ. Rubinow DR. (1997) Neuroregulatory role of gonadal steroids in humans. Psychopharmacol Bull 33: 219-220.
135. Schneider HJ. Aimaretti G. Kreitschmann-Andermahr I. Stalla GK. Ghigo E. (2007) Hypopituitarism. Lancet 369: 1461-1470.
136. Schneider HJ. Pickel J. Stalla GK. (2006) Typical female 2nd-4th finger length (2D:4D) ratios in male-to-female transsexuals-possible implications for prenatal androgen exposure. Psychoneuroendocrinology 31: 265-269.
137. Schroeder JP. Packard MG. (2000) Role of dopamine receptor subtypes in the acquisition of a testosterone conditioned place preference in rats. Neurosci Lett 282: 17-20.
138. Schulz KM. Menard TA. Smith DA. Albers HE. Sisk CL. (2006) Testicular hormone exposure during adolescence organizes flank-marking behavior and vasopressin receptor binding in the lateral septum. Horm Behav 50: 477-483.
139. Schweiger U. Deuschle M. Weber B. Korner A. Lammers CH. Schmider J. (1999) Testosterone, gonadotropin, and cortisol secretion in male patients with major depression. Psychosom Med 61: 292-296.
140. Seale JV. Wood SA. Atkinson HC. Lightman SL. Harbuz MS. (2005) Organizational role for testosterone and estrogen on adult hypothalamic- pituitary-adrenal axis activity in the male rat. Endocrinology 146: 1973-1982.
141. Seidman SN. (2003) Testosterone deficiency and mood in aging men: pathogenic and therapeutic interactions. World J Biol Psychiatry 4: 14-20.
142. Seidman SN. (2006) Normative hypogonadism and depression: Does 'andropause' exist. Int J Impot Res 18: 415-422.
143. Seidman SN. Araujo AB. Roose SP. Devanand DP. Xie S. Cooper TB. (2002) Low testosterone levels in elderly men with dysthymic disorder. Am J Psychiatry 159: 456-459.
144. Seidman SN. Araujo AB. Roose SP. McKinlay JB. (2001a) Testosterone level, androgen receptor polymorphism, and depressive symptoms in middle-aged men. Biol Psychiatry 50: 371-376.
145. Seidman SN. Miyazaki M. Roose SP. (2005) Intramuscular testosterone supplementation to selective serotonin reuptake inhibitor in treatment-resistant depressed men: randomized placebo-controlled clinical trial. J Clin Psychopharmacol 25: 584-588.
146. Seidman SN. Rabkin JG. (1998) Testosterone replacement therapy for hypogonadal men with SSRI-refractory depression. J Affect Disord 48: 157-161.
147. Seidman SN. Roose SP. (2006) The sexual effects of testosterone replacement in depressed men: randomized, placebo-controlled clinical trial. J Sex Marital Ther 32: 267-273.
148. Seidman SN. Spatz E. Rizzo C. Roose SP. (2001b) Testosterone replacement therapy for hypogonadal men with major depressive disorder: a randomized, placebo-controlled clinical trial. J Clin Psychiatry 62: 406-412.
149. Seidman SN. Walsh BT. (1999) Testosterone and depression in aging men. Am J Geriatr Psychiatry 7: 18-33.
150. Shemisa K. Kunnathur V. Liu B. Salvaterra TJ. Dluzen DE. (2006) Testosterone modulation of striatal dopamine output in orchidectomized mice. Synapse 60: 347-353.
151. Sherwin BB. (1988) Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. J Affect Disord 14: 177-187.
152. Shifren JL. (2002) Androgen deficiency in the oophorectomized woman. Fertil Steril 77 (Suppl. 4). S60-S62.
153. Shores MM. Moceri VM. Sloan KL. Matsumoto AM. Kivlahan DR. (2005) Low testosterone levels predict incident depressive illness in older men: effects of age and medical morbidity. J Clin Psychiatry 66: 7-14.
154. Shores MM. Sloan KL. Matsumoto AM. Moceri VM. Felker B. Kivlahan DR. (2004) Increased incidence of diagnosed depressive illness in hypogonadal older men. Arch Gen Psychiatry 61: 162-167.
155. Sih R. Morley JE. Kaiser FE. Perry HM. Patrick P. Ross C. (1997) Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab 82: 1661-1667.
156. Steidle C. Schwartz S. Jacoby K. Sebree T. Smith T. Bachand R. (2003) AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function. J Clin Endocrinol Metab 88: 2673-2681.
157. Steiner M. Dunn E. Born L. (2003) Hormones and mood: from menarche to menopause and beyond. J Affect Disord 74: 67-83.
158. Stoffel-Wagner B. (2001) Neurosteroid metabolism in the human brain. Eur J Endocrinol 145: 669-679.
159. Su TP. Pagliaro M. Schmidt PJ. Pickar D. Wolkowitz O. Rubinow DR. (1993) Neuropsychiatric effects of anabolic steroids in male normal volunteers. JAMA 269: 2760-2764.
160. Sun MK. Alkon DL. (2006) Differential gender-related vulnerability to depression induction and converging antidepressant responses in rats. J Pharmacol Exp Ther 316: 926-932.
161. Swaab DF. Bao AM. Lucassen PJ. (2005) The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev 4: 141-194.
162. Szczypka MS. Zhou QY. Palmiter RD. (1998) Dopamine-stimulated sexual behavior is testosterone dependent in mice. Behav Neurosci 112: 1229-1235.
163. T'sjoen G. G., De Vos, S, Goemaere, S, Van Pottelbergh, I, Dierick, M, Van Heeringen, C, Kaufman, JM (2005) Sex steroid level, androgen receptor polymorphism, and depressive symptoms in healthy elderly men. J Am Geriatr Soc 53: 636-642.
164. Tan RS. Salazar JA. (2004) Risks of testosterone replacement therapy in ageing men. Expert Opin Drug Saf 3: 599-606.
165. Tricker R. Casaburi R. Storer TW. Clevenger B. Berman N. Shirazi A. (1996) The effects of supraphysiological doses of testosterone on angry behavior in healthy eugonadal men-a clinical research center study. J Clin Endocrinol Metab 81: 3754-3758.
166. Unden F. Ljunggren JG. Beck-Friis J. Kjellman BF. Wetterberg L. (1988) Hypothalamic-pituitary-gonadal axis in major depressive disorders. Acta Psychiatr Scand 78: 138-146.
167. Vermeulen A. Kaufman JM. (1995) Ageing of the hypothalamo-pituitary- testicular axis in men. Horm Res 43: 25-28.
168. Vogel W. Klaiber EL. Broverman DM. (1985) A comparison of the antidepressant effects of a synthetic androgen (mesterolone) and amitriptyline in depressed men. J Clin Psychiatry 46: 6-8.
169. Wang C. Alexander G. Berman N. Salehian B. Davidson T. McDonald V. (1996) Testosterone replacement therapy improves mood in hypogonadal men-a clinical research center study. J Clin Endocrinol Metab 81: 3578-3583.
170. Wang C. Cunningham G. Dobs A. Iranmanesh A. Matsumoto AM. Snyder PJ. (2004) Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab 89: 2085-2098.
171. Wang C. Swerdloff RS. Iranmanesh A. Dobs A. Snyder PJ. Cunningham G. (2000) Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab 85: 2839-2853.
172. Weissman MM. Olfson M. (1995) Depression in women: implications for health care research. Science 269: 799-801.
173. Weltzien FA. Pasqualini C. Sebert ME. Vidal B. Le Belle N. Kah O. (2006) Androgen-dependent stimulation of brain dopaminergic systems in the female European eel (Anguilla anguilla). Endocrinology 147: 2964-2973.
174. Wierman ME. Basson R. Davis SR. Khosla S. Miller KK. Rosner W. (2006) Androgen therapy in women: an Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab 91: 3697-3710.
175. Wilson IC. Prange AJ. Lara PP. (1974) Methyltestosterone with imipramine in men: conversion of depression to paranoid reaction. Am J Psychiatry 131: 21-24.
176. Winnay JN. Xu J. O'malley, BW, Hammer, GD (2006) Steroid receptor coactivator-1-deficient mice exhibit altered hypothalamic-pituitary-adrenal axis function. Endocrinology 147: 1322-1332.
177. Yates WR. Perry PJ. MacIndoe J. Holman T. Ellingrod V. (1999) Psychosexual effects of three doses of testosterone cycling in normal men. Biol Psychiatry 45: 254-260.
178. Zarate CA. Singh JB. Carlson PJ. Brutsche NE. Ameli R. Luckenbaugh DA. (2006) A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63: 856-864.
179. Zweifel JE. O'brien, WH (1997) A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology 22: 189-212.